期刊文献+

11β-羟基类固醇脱氢酶通过改变糖皮质激素活性参与机体多个病理环节 被引量:8

11β-HSD Involved in Pathological Link through the Conversion of Glucocorticoid
下载PDF
导出
摘要 11β-羟基类固醇脱氢酶(11β-HSD)是糖皮质激素的代谢酶,该酶分为11β-HSD1与11β-HSD2两种亚型。11β-HSD1使无活性的可的松转化为有活性的氢化可的松,参与了肥胖、高血脂、高血糖、高血压等代谢综合征的病理生理过程。另外,高水平的糖皮质激素暴露与神经系统功能紊乱及年龄相关性认知功能障碍有关。11β-HSD2通过使糖皮质激素失活起到保护盐皮质激素受体的作用。反之,11β-HSD2基因缺陷或突变会导致高盐皮质激素综合征,表现为水钠潴留、高血压、低血钾。通过对11β-HSD的功能及其作用机制的深入研究,为代谢综合征及其相关疾病提供了新的治疗方法。 11β-hydroxysteroid dehydrogenase( 11β-HSD) catalyses the conversion of inactive to active glucocorticoids. Two isozymes have been discovered, each with unique properties and powerful biological roles. 11β-HSD1 converts inactive cortisone to active cortisol. Excessive glucocorticoid exposure causes obesity ,hyperlipidemia, hyperglycemia, hypertension, which are collectively called metabolic syndrome. Moreover, high levels of giucocorticoids can cause neuropsychiatric dysfunction and cognitive impairments. 11β-HSD2 prevents the stimulation of mineralocorticoid receptor by converting active cortisol to inactive cortisone. Conversely, 11β-HSD2 gene defect or mutation can cause high mineral corticoid syndrome such as sodium reabsorption, hypertension and hypokalemia. More detailed discussion of 11β-HSD will provide novel therapeutic target for metabolic disease and many other related diseases.
出处 《医学综述》 2013年第1期40-42,共3页 Medical Recapitulate
关键词 11Β-羟基类固醇脱氢酶 糖皮质激素 认知 代谢综合征 高血压 11β-hydroxysteroid dehydrogenase Glucocorticoid Cognition Metabolic syndrome Hy- pertension
  • 相关文献

参考文献25

  • 1Stulnig TM, Waldhansl W. 11 beta-hydmxysteroid dehydrogenase type 1 in obesity and type 2 diabetes [ J ]. Diabetologia, 2004,47 (1) :1-11. 被引量:1
  • 2Eijken M, Hewison M, Cooper MS,et al. 1 lbeta-Hydroxysteroid de- hydrogenase expression and glucoeorticoid synthesis are directed by a molecular switch during osteoblast differentiation[ J]. Mol Endo- crino1,2005,19 ( 3 ) :621-631. 被引量:1
  • 3Wake D J, Walker BR. 11 beta-hydroxysteroid dehydrogenase type 1 in obesity and the metabolic syndrome [ J ]. Mol Cell Endocrinol, 2004,215 ( 1/2 ) :45-54. 被引量:1
  • 4Wan SL, Liao MY, Sun K, et al. Postnatal development of 11 beta- hydmxysteroid dehydrogenase type 1 in the rat bippocampus[ J]. J Neurosci Res,2002,69 (5) :681-686. 被引量:1
  • 5Yan JL, Noble J, Kenyon C J, et al. Lack of tissue glucocorticoid re- activation in 11 beta-hydroxysteriod dehydrogenase type 1 knockout mice ameliorates age-related learning impairments [ J ]. Proe Natl Aead Sei U S A,2001,98(8) :4716-4721. 被引量:1
  • 6Mattsson C, Lai M, Noble J, et al. Obese Zucker rats have reduced mineralocortieoid receptor and 11 beta-hydroxysteroid dehydrogen- ase type 1 expression in hippocampus-implicatians for dysregulationof the hypothalamic-pituitary-adrenal axis in obesity [ J ]. Endocri- nology,2003 144(7) :2997-3003. 被引量:1
  • 7Kopelman PG. Obesity as a medical problem [ J ]. Nature, 2000, 404(6778 ) :635-643. 被引量:1
  • 8Baudrand R, Carvajal CA, Riquelme A, et al. Overexpression of 11 beta-hydroxysteroid dehydrogenase type 1 in hepatic and visceral adipose tissue is associated with metabolic disorders in morbidly obese patients[ J]. Obes Surg,2010,20( 1 ) :77-83. 被引量:1
  • 9Masuzaki H,Paterson J, Shinyama H, et al. A transgenic model of visceral obesity and the metabolic syndrome [ J ]. Science, 2001, 294(5549) :2166-2170. 被引量:1
  • 10Morton NM, Paterson JM, Masuzaki H, et al. Novel adipose tissue- mediated resistance to diet-induced visceral obesity in 11 beta- hydroxysteroid dehydrogenase type 1-deficient mice [ J ]. Diabetes, 2004,53(4) :931-938. 被引量:1

同被引文献52

引证文献8

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部